Emergence of a novel tigecycline resistance gene cluster tmexC3-tmexD5-toprJ2b in Oceanimonas sp. from chicken, China.

J Antimicrob Chemother

Jiangsu Key Laboratory of Zoonosis/Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.

Published: May 2023

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkad080DOI Listing

Publication Analysis

Top Keywords

emergence novel
4
novel tigecycline
4
tigecycline resistance
4
resistance gene
4
gene cluster
4
cluster tmexc3-tmexd5-toprj2b
4
tmexc3-tmexd5-toprj2b oceanimonas
4
oceanimonas chicken
4
chicken china
4
emergence
1

Similar Publications

Evolution of artificial intelligence in healthcare: a 30-year bibliometric study.

Front Med (Lausanne)

January 2025

Department of Cardiology, Heart Center, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Introduction: In recent years, the development of artificial intelligence (AI) technologies, including machine learning, deep learning, and large language models, has significantly supported clinical work. Concurrently, the integration of artificial intelligence with the medical field has garnered increasing attention from medical experts. This study undertakes a dynamic and longitudinal bibliometric analysis of AI publications within the healthcare sector over the past three decades to investigate the current status and trends of the fusion between medicine and artificial intelligence.

View Article and Find Full Text PDF

Emerging engineered nanozymes: current status and future perspectives in cancer treatments.

Nanoscale Adv

January 2025

Cancer Center, Department of Interventional Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College Hangzhou Zhejiang China

Composite nanozymes are composed of enzymes with similar or different catalytic capabilities and have higher catalytic activity than a single enzyme. In recent years, composite nanozymes have emerged as novel nanomaterial platforms for multiple applications in various research fields, where they are used to produce oxygen, consume glutathione, or produce toxic reactive oxygen species (ROS) for cancer therapy. The therapeutic approach using composite nanozymes is known as chemo-dynamic therapy (CDT).

View Article and Find Full Text PDF

Strategies emphasizing animal-free innovation are imperative for the contemporary and future scientific research. They not only address important ethical concerns, but also should directly improve research accuracy and reliability through redirecting scientific inquiry toward more reliable and translatable methodologies. Promotion and encouragement for use of animal-free innovations among the next-generation of scientists, alongside knowledge acquisition and training in the increased capabilities of novel technologies, are fundamental for advancing science and the welfare of animals used for scientific purposes.

View Article and Find Full Text PDF

A scoping review and expert consensus on digital determinants of health.

Bull World Health Organ

February 2025

LSE Health, Department of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, London, England.

Objective: To map how social, commercial, political and digital determinants of health have changed or emerged during the recent digital transformation of society and to identify priority areas for policy action.

Methods: We systematically searched MEDLINE, Embase and Web of Science on 24 September 2023, to identify eligible reviews published in 2018 and later. To ensure we included the most recent literature, we supplemented our review with non-systematic searches in PubMed® and Google Scholar, along with records identified by subject matter experts.

View Article and Find Full Text PDF

Introduction: Hypertrophic cardiomyopathy (HCM) is a common genetic heart disorder. It is characterized by left ventricular hypertrophy and impaired cardiac function, with forms categorized into obstructive (oHCM) and nonobstructive (nHCM). Traditional treatments address symptoms but not the underlying disease mechanism, highlighting the need for novel therapies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!